Lu, Qiaomiao
Long, Yu
Fan, Kevin
Shen, Zhiwen
Gai, Yongkang
Liu, Qingyao
Jiang, Dawei
Cai, Weibo
Wan, Chidan
Lan, Xiaoli http://orcid.org/0000-0002-7263-7399
Funding for this research was provided by:
National Natural Science Foundation of China (82030052)
Article History
Received: 11 February 2022
Accepted: 16 June 2022
First Online: 28 June 2022
Declarations
:
: All experimental schemes were performed under the guidance and approved by the Institutional Animal Care and Use Committee of Tongji Medical College of Huazhong University of Science and Technology. Extensive efforts were made to ensure minimal suffering of the animals used during the study.
: Weibo Cai is a scientific advisor, stockholder, and grantee of Focus-X Therapeutics, Inc. All other authors declare no conflict of interest.